NCT06457776View on ClinicalTrials.gov

Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs

RecruitingOBSERVATIONAL
Enrollment

126

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2028

Conditions
Osteonecrosis of the JawOsteonecrosis Due to Drugs, JawOsteonecrosis Due to DrugBisphosphonate-Associated OsteonecrosisBisphosphonate-Associated Osteonecrosis of the Jaw
Interventions
PROCEDURE

Dental management

The oral conditions of the included patients will be evaluated at baseline. When indicated, dental extractions will be performed before the beginning of Antiresorptive Therapy. Patients will then receive a six-months intervals follow-up, during which primary and secondary prevention of dental diseases will be performed.

Trial Locations (1)

00168

RECRUITING

Cosimo Rupe, Roma

All Listed Sponsors
lead

Catholic University of the Sacred Heart

OTHER